TapImmune Inc.
Records under this name other than patents TapImmune Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to TapImmune Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,030,252 | Chimeric Nucleic Acid Molecules with Non-Aug Translation Initiation Sequences and Uses Thereof Formerly held Lapsed on the fee record Ended Jul 24, 2026 · High confidence | Lapsed on the fee record | Ended Jul 24, 2026 | High confidence |
| US 9,364,523 | A chimeric nucleic acid molecule with non-AUG translation initiation sequences Formerly held Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 9,988,643 | Chimeric Nucleic Acid Molecules with Non-Aug Translation Initiation Sequences and Uses Thereof Formerly held Lapsed on the fee record Ended Jun 5, 2022 · High confidence | Lapsed on the fee record | Ended Jun 5, 2022 | High confidence |
| US 9,655,956 | Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof Formerly held Lapsed on the fee record Ended May 23, 2021 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2021 | From the USPTO record |
| US 7,994,146 | Method of Enhancing an Immune Response Lapsed on the fee record Ended Aug 9, 2015 · Medium confidence | Lapsed on the fee record | Ended Aug 9, 2015 | Medium confidence |
| US 7,976,850 | Pox Viridae Treatment Lapsed on the fee record Ended Jul 12, 2015 · High confidence | Lapsed on the fee record | Ended Jul 12, 2015 | High confidence |
| US 7,378,087 | Method of Enhancing an Immune Response Term ended Ended no later than Sep 23, 2014 · Low confidence | Term ended | Ended no later than Sep 23, 2014 | Low confidence |
| US 6,361,770 | Method of enhancing expression of MHC class I molecules bearing endogenous peptides Lapsed on the fee record Ended Mar 26, 2014 · From the USPTO record | Lapsed on the fee record | Ended Mar 26, 2014 | From the USPTO record |
| US 5,792,604 | Method of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathway Term ended Term ended no later than Aug 11, 2018 · Low confidence | Term ended | Term ended no later than Aug 11, 2018 | Low confidence |